Featured Articles
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
Keeping The Momentum In Pandemic Preparedness
10/22/2024
Learn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.
-
Is Industry Ready To Take A Bite Out Of Obesity?
7/15/2024
What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?
-
New And Upcoming Trends In Immunodiagnostics
7/15/2024
Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.
-
CAR T Set The Pace So All Can Win The Cell Therapy Race
7/15/2024
Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.
-
Revolutionizing Drug Discovery From "Undruggables" To AI
6/10/2024
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
-
Revolutionizing Drug Discovery: The Rise Of Fashionable Models
6/6/2024
As a result of advancements in research technology, "fashionable models" such as organoids and organs-on-chips (OoCs) have been developed. Explore organoid and OoC technologies in detail.
-
Nucleic Acid Therapeutics And Environmental Impact
4/11/2024
Nucleic acid therapeutics offer exciting new avenues of treatment. Learn about the history of nucleic acid therapeutics and the environmental impact of manufacturing mRNA and oligonucleotides.
-
Building Biopharma Resilience In Developing Gene Therapies
3/21/2024
Learn about the opportunities and challenges surrounding gene therapies, the importance of collaboration between biopharma startups and academia, difficulties with the talent pipeline, and more.
-
Big Risks Yield Great Rewards In Cell Therapy
2/14/2024
George White, Cytiva’s GM of Product Management for Cell and Gene Therapy, provides insight into the latest developments and strategies in cell therapy and where this dynamic field is headed.